XBiotech Inc. (XBIT) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM). Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Price / Book | 0.54 |
| FCF Yield | -34.2% |
| Sector P/E (Healthcare) | 21.7 |
XBIT overview · XBIT earnings · XBIT KPIs · XBIT investor relations · XBIT ownership · XBIT peers · XBIT filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.